Saturday, June 29, 2024

June 24, 2024 at 04:13PM Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program

Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rW9OxIi

Friday, June 28, 2024

June 28, 2024 at 08:36PM Administrative Guidances

This page lists Administrative Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/v7DPF82

June 28, 2024 at 02:55PM Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological Products

To facilitate and streamline development of stand-alone devices, and combination products with device constituent parts, intended to deliver drugs and biological products, by improving the consistency of drug delivery performance information developed and included in applications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4rCVGmv

Thursday, June 27, 2024

June 27, 2024 at 09:26PM KYMRIAH

KYMRIAH is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WZ2I5Ua

June 27, 2024 at 06:56PM FDA Opens Doors for More Treatments for Rare Diseases through the New START Pilot Program

FDA is taking steps to help accelerate the development of novel drugs and biologics through the Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program. Learn more.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/U5Wld9E

June 27, 2024 at 04:19PM The Concerning Trend in Men’s Health

Despite spending more on healthcare than any other nation on earth, life expectancy in the U.S. is trending downward.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/pznZQBU

Wednesday, June 26, 2024

June 26, 2024 at 08:36PM Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies Modified to Minimize Burden on Healthcare Delivery System

Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies Modified to Minimize Burden on Healthcare Delivery System

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/mIchFQB

Tuesday, June 25, 2024

June 25, 2024 at 09:34PM Recently Issued Guidance Documents

This page lists Recently Issued CBER and Cross-Center Guidance Documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/nq738KY

June 25, 2024 at 07:43PM Biosimilars Guidances

This page lists Biosimilars Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KOVu4Mg

June 25, 2024 at 03:20PM Indiana Lions Eye Bank, Inc. dba VisionFirst Indiana Lions Eye Bank - 680039 - 06/10/2024

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zIyEsn9

Monday, June 24, 2024

June 24, 2024 at 08:22PM Vaccines and Related Biological Products Advisory Committee June 5, 2024 Meeting Announcement - 06/05/2024

This is the main page for the Vaccines and Related Biological Products Advisory Committee (VRBPAC) June 5, 2024 Meeting announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Dvr8j2q

June 24, 2024 at 04:10PM Testing Human Cells, Tissues, and Cellular and Tissue Based Product (HCT/P) Donors for Relevant Communicable Disease Agents and Diseases

Testing HCT/P Donors for Relevant Communicable Diseases

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Gozpg5c

June 24, 2024 at 04:02PM Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays

Links to the different types of Donor Screening Assays. A table for each assay is provided with detailed information such as tradename, infectious agent, format, specimen, use, manufacturer, approval date, and STN.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/NIuySRD

June 24, 2024 at 03:01PM Laboratory Developed Tests: Small Entity Compliance Guide

FDA has prepared this document to assist small entities in complying with the requirements established in FDA regulations as they apply to IVDs, including LDTs.


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/VDcHAJE

Friday, June 21, 2024

June 20, 2024 at 05:22PM Patient Engagement Collaborative

The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Office of Patient Affairs in the Office of Clinical Policy and Programs (OCPP).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FSv053D

Thursday, June 20, 2024

June 20, 2024 at 11:24PM FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

The FDA expanded the approval of Elevidys, a gene therapy for the treatment of Duchenne muscular dystrophy for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/t6MIYE8

June 20, 2024 at 11:07PM International Activities

CBER’s international activities can be categorized in the following functional areas: regulatory harmonization, regulatory capacity building, information sharing, international standards setting, and collaborative research.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/uXU90eF

June 20, 2024 at 06:20PM TRUMENBA

Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/hn1p9FP

June 20, 2024 at 05:37PM Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection

Guidance for industry on Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/BldIPYe

Tuesday, June 18, 2024

June 18, 2024 at 06:13PM What happens after a Patient Listening Session?

Learn about what happens after a Patient Listening Session occurs and check out summaries from previous sessions on our website.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/B73dF5p

June 18, 2024 at 05:28PM Blood Products Advisory Committee May 9, 2024 Meeting Announcement - 05/09/2024

This is the main page for the Blood Products Advisory Committee May 9, 2024 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Ku4gt5s

June 18, 2024 at 04:45PM Cleared 510(k) Submissions with Supporting Documents

Listing of cleared 510(k) submissions with supporting documents. Information is reflected as of the clearance date.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/QqNdxOI

June 18, 2024 at 03:20PM Neobiosis, LLC - 662985 - 06/05/2024

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/GNyMrwB

Monday, June 17, 2024

June 17, 2024 at 06:00PM Expanded Access (Compassionate Use) Submission Data

Expanded Access (Compassionate Use) Submission Data

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/oGa6TyW

June 14, 2024 at 10:01PM Standards Development for Regenerative Medicine Therapies

Section 3036 of the 21st Century Cures Act refers to the development of standards for regenerative medicine therapies, including products designated regenerative medicine advanced therapies.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/roTgcbO

Sunday, June 16, 2024

Cucumber Recall Update As FDA Sets Highest Risk Level - Newsweek

  1. Cucumber Recall Update As FDA Sets Highest Risk Level  Newsweek
  2. FDA cucumber recall: Salmonella cases rise among those who ate them  USA TODAY
  3. Publisher's Platform: Fresh Start Produce – I would not claim that your cucumbers are not the cause of the Salmonella outbreak  Food Safety News
  4. Salmonella outbreak from recalled cucumbers impacts Delaware, What you should know  The News Journal
  5. Florida cucumbers recalled for salmonella might not be outbreak source  Daytona Beach News-Journal


via Top stories - Google News https://ift.tt/BvGefma

Cucumber Recall Update As FDA Sets Highest Risk Level - Newsweek

  1. Cucumber Recall Update As FDA Sets Highest Risk Level  Newsweek
  2. FDA cucumber recall: Salmonella cases rise among those who ate them  USA TODAY
  3. Cucumber Recall Update as FDA Reveals Hospitalizations, Map  Newsweek
  4. Publisher's Platform: Fresh Start Produce – I would not claim that your cucumbers are not the cause of the Salmonella outbreak  Food Safety News
  5. Florida cucumbers recalled for salmonella might not be outbreak source  Daytona Beach News-Journal


via Top stories - Google News https://ift.tt/BvGefma

Friday, June 14, 2024

June 14, 2024 at 08:52PM Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/RcAZ9zP

Thursday, June 13, 2024

June 14, 2024 at 03:12AM TECARTUS

For the treatment of adult patients with relapsed or refractory (r/r) B-cell precursor acute lymphoblastic leukemia (B-ALL). For the treatment of adult patients with relapsed/refractory mantle cell lymphoma (r/r MCL).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/SXl7ajE

June 14, 2024 at 01:32AM YESCARTA

For the treatment of adult patients with large B-cell lymphoma that is refractory to first-line chemoimmunotherapy or that relapses within 12 months of first-line chemoimmunotherapy. Axicabtagene ciloleucel is not indicated for the treatment of patients with primary central nervous system lymphoma.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/PcjozIT

June 13, 2024 at 10:03PM Updated COVID-19 Vaccines for Use in the United States Beginning in Fall 2024

FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on June 5, 2024, to discuss and make recommendations on the selection of the 2024-2025 Formula for COVID-19 vaccines for use in the United States beginning in the fall of 2024.



via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/wc3j9z7

June 13, 2024 at 03:57PM Streamlining the Donor Interview Process: Recommendations for Self-Administered Questionnaires

Guidance for Industry: Streamlining the Donor Interview Process: Recommendations for Self-Administered Questionnaires, CBER, biologics, guidance, industry, blood, donor, questionnaire

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/elTR96k

June 13, 2024 at 03:38PM FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information

Guidance for Industry: FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed http://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-review-vaccine-labeling-requirements-warnings-use-instructions-and-precautionary-information

June 11, 2024 at 09:21PM Patient Listening Session Summaries

Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Office of Patient Affairs draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/10iUmcF

Wednesday, June 12, 2024

June 12, 2024 at 03:13PM VAXCHORA

VAXCHORA is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/9KTI6s4

Tuesday, June 11, 2024

June 11, 2024 at 09:35PM FDA Roundup: June 11, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/5rO8QFd

June 11, 2024 at 07:13PM COVID-19 Vaccines

FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/R0WQlXK

Monday, June 10, 2024

June 10, 2024 at 03:36PM BIMO/Team Biologics/Internet Surveillance/Other

This is the main page for the CBER BIMO/Team Biologics/Internet Surveillance/Other.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Mb3U5ha

Friday, June 7, 2024

June 07, 2024 at 09:44PM FDA Roundup: June 7, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/I9VGNsl

June 07, 2024 at 07:37PM CBER-Regulated Products: Shortages and Discontinuations

A CBER-regulated product shortage occurs when a CBER-regulated product is not commercially available in sufficient quantity to meet the demand.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/t7VDIxE

June 07, 2024 at 03:20PM Coronavirus (COVID-19) | CBER-Regulated Biologics

This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/BEsG0dD

Thursday, June 6, 2024

June 06, 2024 at 03:10PM Guidance and Other Information of Special Interest to MCM Stakeholders

Information of particular interest to sponsors/applicants of medical countermeasures to treat, prevent, diagnose, and detect chemical, biological, radiological, and nuclear threats and emerging infectious diseases

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/djbS3Lr

Wednesday, June 5, 2024

Cucumbers linked to salmonella outbreak that has spread to 25 states - CBS News

  1. Cucumbers linked to salmonella outbreak that has spread to 25 states  CBS News
  2. Salmonella Outbreak Linked to Cucumbers  CDC
  3. Cucumbers shipped to 14 states recalled over Salmonella concerns  NBC News
  4. Outbreak Investigation of Salmonella: Cucumbers (June 2024)  FDA.gov
  5. More than 160 sickened in salmonella outbreak potentially linked to recalled cucumbers  CNN


via Top stories - Google News https://ift.tt/taMsmEY

Cucumbers linked to salmonella outbreak that has spread to 25 states - CBS News

  1. Cucumbers linked to salmonella outbreak that has spread to 25 states  CBS News
  2. Salmonella Outbreak Linked to Cucumbers  CDC
  3. Cucumbers shipped to 14 states recalled over Salmonella concerns  NBC News
  4. Outbreak Investigation of Salmonella: Cucumbers (June 2024)  FDA.gov
  5. Two dozen sickened across NY, NJ and CT due to salmonella outbreak from cucumbers: CDC  NBC New York


via Top stories - Google News https://ift.tt/aHPbmTC

Cucumber recall: FDA investigating cucumbers in nationwide Salmonella outbreak that's sent 54 to the hospital - NBC News

  1. Cucumber recall: FDA investigating cucumbers in nationwide Salmonella outbreak that's sent 54 to the hospital  NBC News
  2. Cucumbers shipped to 14 states recalled over Salmonella concerns  NBC News
  3. Salmonella Outbreak Linked to Cucumbers  CDC
  4. Cucumbers Recalled Over Possible Salmonella Contamination  Health.com
  5. 162 sickened in Salmonella outbreak linked to cucumbers: CDC  The Hill


via Top stories - Google News https://ift.tt/1JbKjM4

June 05, 2024 at 04:45PM Testing Human Cells, Tissues, and Cellular and Tissue Based Product (HCT/P) Donors for Relevant Communicable Disease Agents and Diseases

Testing HCT/P Donors for Relevant Communicable Diseases

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4AzxcX9

June 05, 2024 at 04:40PM Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays

Links to the different types of Donor Screening Assays. A table for each assay is provided with detailed information such as tradename, infectious agent, format, specimen, use, manufacturer, approval date, and STN.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WvMKPGS

June 05, 2024 at 02:30PM Standardized Format for Electronic Submission for Marketing Applications Content for the Planning of Bioresearch Monitoring (BIMO) Inspections for Center of Biologics Evaluation and Research Submissions

This is the Draft Guidance for Industry Standardized Format for Electronic Submission for Marketing Applications Content for the Planning of Bioresearch Monitoring Inspections for Center for Biologics Evaluation and Research Submissions

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/eYVZSLz

Tuesday, June 4, 2024

June 04, 2024 at 08:28PM FDA Roundup: June 4, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/0tnNgYO

June 04, 2024 at 03:01PM Processes and Practices Applicable to Bioresearch Monitoring Inspections

Processes and Practices Applicable to Bioresearch Monitoring Inspections; Draft Guidance for Industry

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dfjQkDz